UnitedHealth Group saw a 31.24% stock bounce after a strong Q1 earnings beat, but faces significant challenges including a 41.26% drop in 2025 operating income, loss of Medicare Advantage members, regulatory pressures, and costly legal and cyberattack issues. Management's 2026 revenue guidance reflects a strategic decline due to member exits, raising concerns about future profitability. In contrast, Procter & Gamble offers stable, growing dividends with consistent revenue and cash flow growth, reaffirming strong earnings guidance despite tariffs. Costco also shows robust cash flow and membership growth, providing a reliable alternative for retirement-focused investors wary of UnitedHealth's regulatory risks.
Piper Sandler raised its price target for UnitedHealth Group to $475, suggesting a 13.3% upside from its current price of $419.23. The company, the largest U.S. health insurer, has consistently beaten earnings estimates, with its latest EPS of $7.23 ...
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
Elevance Health and UnitedHealth Group, two of the largest U.S. health insurers, are set to report their second-quarter earnings this week. Investors and analysts are watching closely to see if these companies have maintained control over rising medi...
